Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

LEGACY02

Examining lymph node cells to assess how age affects immune responses

You are invited to take part in a study examining lymph node cells to assess how age affects immune responses to a new vaccine. The study is being led by the Oxford Vaccine Group, University of Oxford, which is part of the University of Oxford, and is taking place at the Oxford Vaccine Group, University of Oxford.

If you are either 18 to 45 years old or 65+ years old, in good health and live in the Oxford Vaccine Group, University of Oxford area, then you may be eligible to take part. We will provide reimbursement of up to £1110 for your time, inconvenience and travel. The total study participation time is 6 months.

If you would like to find out more, please read the Participant Information Sheet.

If you are interested in joining the study, please visit LEGACY02 Pre-Screening Questionnaire where you can access the online screening questions and register your interest.

If you would like any further information regarding the study, please contact us on:

Email: info@ovg.ox.ac.uk

Telephone: 01865 611400

Study

LEGACY02: Examining lymph node cells to assess how age affects immune responses

Questions?

Email  info@ovg.ox.ac.uk

Telephone 01865 611400

Links